A heavily pre-treated adenocarcinoma patient with EGFR exon 20 insertion mutation responded to pembrolizumab plus nab-paclitaxel/bevacizumab: a case report
2020 ◽
Vol 9
(5)
◽
pp. 3-3
Xiaojie Huang
◽
Yan Yang
◽
Pingli Wang
◽
Han Han-Zhang
◽
Liren Ding
2019 ◽
Vol 14
(10)
◽
pp. S575-S576
G. Bravo Montenegro
◽
C. Kim
2021 ◽
Vol 11
(11)
◽
pp. 5358-5363
2019 ◽
Vol 19
(1)
◽
pp. e7-e11
◽
Apurva Pandey
◽
Adam M. Brufsky
2018 ◽
Vol 14
◽
pp. 7-9
◽
2021 ◽
Vol 0
(0)
◽
pp. 0-0
Yunfei Ma
◽
Hui Liu
◽
Min Zhang
◽
Bailong Liu
◽
Qiuhui Ding
◽
...
Josette Kamel
◽
Natalie Meeder
◽
Sandra Cuellar
◽
David Chan, Pharm.D
◽
Michael Huber
◽
...
2021 ◽
Vol Volume 14
◽
pp. 5315-5319
Yuki Kato
◽
Yasuhiro Kato
◽
Yuji Minegishi
◽
Takahiro Suzuki
◽
Shinji Nakamichi
◽
...
Chiho Miyagawa
◽
Hisamitsu Takaya
◽
Kazuko Sakai
◽
Kazuto Nishio
◽
Maho Konishi
◽
...
2019 ◽
Vol 14
(10)
◽
pp. e220-e221
◽
Wenfeng Fang
◽
Yihua Huang
◽
Jiadi Gan
◽
Yang W. Shao
◽
Li Zhang
2021 ◽
Vol 100
(29)
◽
pp. e26650
Jingying Nong
◽
Yanfei Gu
◽
Shuyang Yao
◽
Yi Zhang
Close
Export Citation Format
Close
Share Document
Close